CytoSorbents makes blood purification cartridges that remove toxins and inflammatory substances from blood for hospitals and veterinary clinics. It last closed at $4.16 on Nov 20, down 18.91% on the day. The next earnings report for CTSO is expected around Wed, Mar 24, 2027, after the close. For the quarter ended Sep 2026, CTSO reported EPS of -$0.65 on revenue of $9.7M, with revenue up 2.6% from a year ago. Over its last 8 reports the stock moved an average of 8.0% the session after earnings. Over the last 12 months CTSO insiders bought $269K of stock on the open market and sold $0, according to SEC Form 4 filings.
AI Auto Pilots
Is CTSO in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CTSO.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on CTSOStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
CTSO · as of the Nov 20 close · updated each morning
Downtrend
The stock is 17% below its 20 day and 13% below its 50 day average. It is 113% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 43). The nearest support is the swing low (Oct 26) at $4.10, and the nearest resistance the Pivot at $4.49.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 19.2%/day
Key levels
$17.0052 week high+308.7%
$8.85200 day average+112.7%
$6.13Swing high (Nov 9)+47.4%
$6.00100 day average+44.2%
$4.8820 day average+17.3%
$4.81Pivot R1+15.6%
$4.7050 day average+13.0%
$4.49Pivot+7.9%
$4.16Last close
$4.10Swing low (Oct 26)−1.4%
$3.83Pivot S1−7.9%
$2.8452 week low−31.7%
Indicators
RSI (14)
43.41
Middle of its range
Neutral
MACD
0.03
Below its signal line
Bearish
Stochastic
46.2
Middle of its range
Neutral
ADX (14)
15.5
No clear trend
Williams %R
-95.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-69.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−13.3%
Change over 10 sessions
Bearish
ATR (14)
$0.80
Typical daily range, 19.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 40.8%/day
Key levels
$17.0052 week high+308.7%
$8.85200 day average+112.7%
$6.13Swing high (Nov 9)+47.4%
$6.00100 day average+44.2%
$4.8820 day average+17.3%
$4.81Pivot R1+15.6%
$4.7050 day average+13.0%
$4.49Pivot+7.9%
$4.16Last close
$4.10Swing low (Oct 26)−1.4%
$3.83Pivot S1−7.9%
$2.8452 week low−31.7%
Indicators
RSI (14)
33.18
Weak, oversold below 30
Neutral
MACD
-1.56
Above its signal line
Bullish
Stochastic
26.8
Middle of its range
Neutral
ADX (14)
11.0
No clear trend
Williams %R
-80.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
-67.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−35.1%
Change over 10 sessions
Bearish
ATR (14)
$1.70
Typical daily range, 40.8% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CTSO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CTSO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow CTSO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for CTSOHow many large options trades hit CTSO, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in CTSO in the last 90 days.
From SEC Form 4 filings by CTSO's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTSO is in one of them and how their past CTSO trades turned out.
CytoSorbents is a medical device company based in Princeton, New Jersey. It makes blood purification cartridges filled with porous polymer beads that remove harmful substances from blood. Its main product, CytoSorb, is sold to hospitals for use in intensive care and cardiac surgery, where it connects to blood pumps already in use. The company also sells products for emergency care in animals and is seeking U.S. approval for a device that removes certain blood thinners during heart surgery.